Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | VAC85135 |
Trade Name | |
Synonyms | VAC-85135|VAC 85135 |
Drug Descriptions |
VAC85135 is a cancer vaccine comprising a viral vector expressing neoantigens, which may result in the induction of a cytotoxic T-lymphocyte (CTL) response against neoantigen-expressing tumor cells (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Ipilimumab + VAC85135 | Ipilimumab VAC85135 | 0 | 1 |
VAC85135 | VAC85135 | 0 | 0 |